| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/15/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 05/04/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 03/30/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 02/16/2023 | 403.14% | HC Wainwright & Co. | $13 → $8 | Maintains | Buy |
| 08/04/2022 | 717.61% | HC Wainwright & Co. | $14 → $13 | Maintains | Buy |
| 11/12/2021 | 151.57% | Jefferies | $3 → $4 | Upgrades | Hold → Buy |
| 12/08/2020 | 843.4% | Roth Capital | $9 → $15 | Maintains | Buy |
| 07/31/2020 | 843.4% | HC Wainwright & Co. | $16 → $15 | Maintains | Buy |
| 03/02/2020 | 906.29% | HC Wainwright & Co. | $18 → $16 | Reiterates | → Buy |
| 11/14/2019 | 654.72% | Roth Capital | → $12 | Initiates Coverage On | → Buy |
| 08/05/2019 | — | Jefferies | Downgrades | Buy → Hold | |
| 08/05/2019 | 214.47% | SunTrust Robinson Humphrey | $23 → $5 | Downgrades | Buy → Hold |
| 08/05/2019 | 277.36% | Piper Sandler | $20 → $6 | Downgrades | Overweight → Neutral |
| 04/12/2019 | — | Piper Sandler | Initiates Coverage On | → Overweight | |
| 12/18/2018 | 1409.43% | HC Wainwright & Co. | → $24 | Initiates Coverage On | → Buy |
What is the target price for GlycoMimetics (GLYC)?
The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on August 3, 2023. The analyst firm set a price target for $8.00 expecting GLYC to rise to within 12 months (a possible 403.14% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for GlycoMimetics (GLYC)?
The latest analyst rating for GlycoMimetics (NASDAQ: GLYC) was provided by HC Wainwright & Co., and GlycoMimetics reiterated their buy rating.
When is the next analyst rating going to be posted or updated for GlycoMimetics (GLYC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GlycoMimetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GlycoMimetics was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
Is the Analyst Rating GlycoMimetics (GLYC) correct?
While ratings are subjective and will change, the latest GlycoMimetics (GLYC) rating was a reiterated with a price target of $0.00 to $8.00. The current price GlycoMimetics (GLYC) is trading at is $1.59, which is within the analyst's predicted range.